6533b854fe1ef96bd12aec23
RESEARCH PRODUCT
Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development
Sebastien GagneuxSonia BorrellDorothy Yeboah-manuJulia FeldmannBouke C. De JongChloé LoiseauMidori Kato-maedaMireia CoscollaAndrej TraunerLeen RigoutsChristian BeiselDaniela BritesMiriam ReinhardStefan Niemannsubject
Bacterial DiseasesResearch FacilitiesExtensively Drug-Resistant TuberculosisLineage (evolution)DiseaseAnimal PhylogeneticsMedicine and Health SciencesPhylogenyData Management0303 health sciencesGeographyPhylogenetic treeStrain (biology)QRGenomics3. Good healthActinobacteriaPhylogeneticsPhylogeographyInfectious DiseasesBiogeographyMycobacterium tuberculosis complexMedicineResearch LaboratoriesResearch ArticleComputer and Information SciencesTuberculosisTuberculosiScienceBiologyResearch and Analysis MethodsMycobacterium tuberculosis03 medical and health sciencesGenomic MedicineGeneticsmedicineTuberculosisHumansEvolutionary SystematicsTaxonomy030304 developmental biologyEvolutionary BiologyPopulation BiologyBacteria030306 microbiologyEcology and Environmental SciencesOrganismsBiology and Life SciencesGenetic VariationMycobacterium tuberculosisTropical Diseasesbiology.organism_classificationmedicine.diseaseGenòmicaPhylogenetic diversityEvolutionary biologyEarth SciencesZoologyPopulation Geneticsdescription
TheMycobacterium tuberculosiscomplex (MTBC) causes tuberculosis (TB) in humans and various other mammals. The human-adapted members of the MTBC comprise seven phylogenetic lineages that differ in their geographical distribution. There is growing evidence that this phylogenetic diversity modulates the outcome of TB infection and disease. For decades, TB research and development has focused on the two canonical MTBC reference strains H37Rv and Erdman, both of which belong to Lineage 4. Relying on only a few laboratory-adapted strains can be misleading as study results might not be directly transferrable to clinical settings where patients are infected with a diverse array of strains, including drug-resistant variants. Here, we argue for the need to expand TB research and development by incorporating the phylogenetic diversity of the MTBC. To facilitate such work, we have assembled a group of 20 genetically well-characterized clinical strains representing the seven known human-adapted MTBC lineages. With the “MTBC clinical strains reference set” we aim to provide a standardized resource for the TB community. We hope it will enable more direct comparisons between studies that explore the physiology of MTBC beyond the lab strains used thus far. We anticipate that detailed phenotypic analyses of this reference strain set will increase our understanding of TB biology and assist in the development of new control tools that are universally effective.
year | journal | country | edition | language |
---|---|---|---|---|
2018-08-25 |